Cetuximab and Radiation Therapy for Surgically Resectable Esophageal and Gastroesophageal (GE) Junction Carcinomas
Clinical trial NCT00319735 · COMPLETED
Trial details
- NCT number
- NCT00319735
- Sponsor
- Nasser Hanna, M.D.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-04-01
- Primary completion
- 2009-01-01
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.